Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 8
1967 2
1968 6
1969 3
1971 4
1972 3
1973 3
1974 11
1975 9
1976 8
1977 13
1978 10
1979 10
1980 11
1981 22
1982 10
1983 8
1984 11
1985 16
1986 10
1987 23
1988 23
1989 25
1990 27
1991 27
1992 36
1993 42
1994 31
1995 45
1996 32
1997 55
1998 62
1999 66
2000 113
2001 114
2002 144
2003 189
2004 201
2005 279
2006 321
2007 355
2008 389
2009 477
2010 572
2011 604
2012 742
2013 797
2014 939
2015 940
2016 932
2017 966
2018 997
2019 1068
2020 1062
2021 1123
2022 1051
2023 244
Text availability
Article attribute
Article type
Publication date

Search Results

13,640 results
Results by year
Filters applied: . Clear all
Page 1
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Gerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, George TI, Gundabolu K, Hexner E, Hobbs GS, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, McMahon B, Mohan SR, Nadiminti KV, Oh S, Pardanani A, Podoltsev N, Rein L, Salit R, Stein BL, Talpaz M, Vachhani P, Wadleigh M, Wall S, Ward DC, Bergman MA, Hochstetler C. Gerds AT, et al. Among authors: oh s. J Natl Compr Canc Netw. 2022 Sep;20(9):1033-1062. doi: 10.6004/jnccn.2022.0046. J Natl Compr Canc Netw. 2022. PMID: 36075392
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Wainberg ZA, Enzinger PC, Kang YK, Qin S, Yamaguchi K, Kim IH, Saeed A, Oh SC, Li J, Turk HM, Teixeira A, Borg C, Hitre E, Udrea AA, Cardellino GG, Sanchez RG, Collins H, Mitra S, Yang Y, Catenacci DVT, Lee KW. Wainberg ZA, et al. Among authors: oh sc. Lancet Oncol. 2022 Nov;23(11):1430-1440. doi: 10.1016/S1470-2045(22)00603-9. Epub 2022 Oct 14. Lancet Oncol. 2022. PMID: 36244398 Clinical Trial.
Editorial: Insights in neuro-otology: 2021 and 2022.
Strupp M, Straka H, Oh SY. Strupp M, et al. Among authors: oh sy. Front Neurol. 2022 Dec 7;13:1104573. doi: 10.3389/fneur.2022.1104573. eCollection 2022. Front Neurol. 2022. PMID: 36570457 Free PMC article. No abstract available.
TMEM100, a Lung-Specific Endothelium Gene.
Liu B, Yi D, Yu Z, Pan J, Ramirez K, Li S, Wang T, Glembotski CC, Fallon MB, Oh SP, Gu M, Kalucka J, Dai Z. Liu B, et al. Among authors: oh sp. Arterioscler Thromb Vasc Biol. 2022 Dec;42(12):1495-1497. doi: 10.1161/ATVBAHA.122.317683. Epub 2022 Oct 13. Arterioscler Thromb Vasc Biol. 2022. PMID: 36252125 Free article.
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial.
Choi KH, Park YH, Song YB, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Oh JH, Chun WJ, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Gwon HC, Hahn JY; SMART-CHOICE Investigators. Choi KH, et al. Among authors: oh sk. JAMA Cardiol. 2022 Nov 1;7(11):1100-1108. doi: 10.1001/jamacardio.2022.3203. JAMA Cardiol. 2022. PMID: 36169938
COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs.
Lee JH, Kanwar B, Khattak A, Balentine J, Nguyen NH, Kast RE, Lee CJ, Bourbeau J, Altschuler EL, Sergi CM, Nguyen TNM, Oh S, Sohn MG, Coleman M. Lee JH, et al. Among authors: oh s. Int J Mol Sci. 2022 Oct 31;23(21):13260. doi: 10.3390/ijms232113260. Int J Mol Sci. 2022. PMID: 36362045 Free PMC article. Review.
Collision-System and Beam-Energy Dependence of Anisotropic Flow Fluctuations.
Abdallah MS, Adam J, Adamczyk L, Adams JR, Adkins JK, Agakishiev G, Aggarwal I, Aggarwal MM, Ahammed Z, Alekseev I, Anderson DM, Aparin A, Aschenauer EC, Ashraf MU, Atetalla FG, Attri A, Averichev GS, Bairathi V, Baker W, Ball Cap JG, Barish K, Behera A, Bellwied R, Bhagat P, Bhasin A, Bielcik J, Bielcikova J, Bordyuzhin IG, Brandenburg JD, Brandin AV, Bunzarov I, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Chakaberia I, Chaloupka P, Chan BK, Chang FH, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chattopadhyay S, Chen D, Chen J, Chen JH, Chen X, Chen Z, Cheng J, Chevalier M, Choudhury S, Christie W, Chu X, Crawford HJ, Csanád M, Daugherity M, Dedovich TG, Deppner IM, Derevschikov AA, Dhamija A, Di Carlo L, Didenko L, Dixit P, Dong X, Drachenberg JL, Duckworth E, Dunlop JC, Elsey N, Engelage J, Eppley G, Esumi S, Evdokimov O, Ewigleben A, Eyser O, Fatemi R, Fawzi FM, Fazio S, Federic P, Fedorisin J, Feng CJ, Feng Y, Filip P, Finch E, Fisyak Y, Francisco A, Fu C, Fulek L, Gagliardi CA, Galatyuk T, Geurts F, Ghimire N, Gibson A, Gopal K, Gou X, Grosnick D, Gupta A, Guryn W, Hamad AI, Hamed A, Han Y, Harabasz S, Harasty MD, Harris JW, Harrison H, He S, He… See abstract for full author list ➔ Abdallah MS, et al. Among authors: oh s. Phys Rev Lett. 2022 Dec 16;129(25):252301. doi: 10.1103/PhysRevLett.129.252301. Phys Rev Lett. 2022. PMID: 36608250
13,640 results
You have reached the last available page of results. Please see the User Guide for more information.